Breaking: Early trial results of Oxford’s Vaccination for Covid-19 expected today
The first trial results of AZD 1222 covid-19 vaccine developed by University of Oxford in England are expected today. It is one of the biggest developments in vaccination process. According to sources 1000 people were tested in first phase and results are expected today.
The main purpose is to check whether it is safe to test on more people. The conclusions of the trials are to be published today in The Lancet — a peer-reviewed weekly medical journal. “Tomorrow Vaccines”. Richard Horton, the editor of The Lancet tweeted on Sunday. The Vaccine developed by University of Oxford is backed by the pharmaceutical giants AstraZeneca.